Feb 23, 2023 / 01:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the VBL Therapeutics and Notable Labs Joint Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded, and a transcript of the call will be filed by VBL with the SEC. After the presentation by VBL Therapeutics and Notable Labs, there will not be a question-and-answer session.
I would now like to hand the conference over to your moderator, Dan Ferry of LifeSci Advisors, Investor Relations consultant for the company.
Daniel Ferry - LifeSci Advisors, LLC - MD & Relationship Manager
Thank you, operator. Good morning, everyone, and welcome to today's call discussing the proposed transaction between VBL Therapeutics and Notable Labs. Today, we will provide prepared remarks and will not be taking questions. Joining me on the call are Professor Dror Harats, CEO of VBL Therapeutics; Dr. Thomas Bock, Chief Executive Officer of Notable Labs; and Joseph Wagner, PhD, Chief Scientific Officer.
Please note that in addition to this morning's press
Vascular Biogenics Ltd and Notable Labs Inc M&A Call Transcript
Feb 23, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers